MedTrace Logo

Cost-Effectiveness of Lung Volume Reduction Surgery

NCT00013156 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2015-04-07

No results posted yet for this study

Summary

Lung volume reduction surgery (LVRS) has been advanced as a therapy to significantly improve quality of life in patients with COPD, but to date no controlled studies have evaluated the impact of LVRS.

Conditions

Interventions

PROCEDURE

Effectiveness of Lung Reduction Therapy

Sponsors & Collaborators

Principal Investigators

  • Hugh F Huizenga, MD MPH · VA Puget Sound Health Care System Seattle Division, Seattle, WA

  • Stephan D. Fihn, MD MPH · VA Puget Sound Health Care System Seattle Division, Seattle, WA

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Completion
2000-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00013156 on ClinicalTrials.gov